Want to join the conversation?
Fiona Swaffield of RBC asked whether the Basel III paper would make a big difference to the company's SLR. $MS CFO Jon Pruzan replied that it could be beneficial to the SLR ratio, but he added that the company does not have a quantification of that just yet.
$YHOO is reporting today after market close. Nobody cares about this stock.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.